Company Quick10K Filing
Leju
20-F 2020-12-31 Filed 2021-04-15
20-F 2019-12-31 Filed 2020-07-15
20-F 2018-12-31 Filed 2019-04-10
20-F 2017-12-31 Filed 2018-04-26
20-F 2016-12-31 Filed 2017-04-21
20-F 2015-12-31 Filed 2016-04-22

Leju Financials

LEJU Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2014-12-312015-12-312016-12-312017-12-312018-12-31
Cash318260274151147
Accounts Receivable1201147181103
Inventory
PP&E1920222925
Assets638627576439417
Accounts Payable00231
Long-Term Debt
Liabilities223203170182175
Stockholders' Equity415425408260244
Income Statement ($MM)2014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($MM)2014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating
Cash Investing
Cash Financing